BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Expense ratio components for Dividend Aristocrats ETFs include management fees and other ongoing costs that reduce net returns.
20,481 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Rivian sits at a pivotal crossroads. This in-depth look weighs cash, partnerships, and a road map for growth to answe...
Pay transparency is surfacing a bigger problem: firms publish pay ranges but struggle to explain how they set actual ...
Target is reeling from included margin pressure and a scale battle with bigger retailers, pushing investors to rethin...
Syndicate Labs, a16z-backed, is closing its development arm after five years of building on-chain tooling, blaming a ...
Hedge funds are loading up on big software names as AI fuels new growth avenues, even as margins come under pressure....
A 75-year-old retiree with a $3 million 401K balance confronts unexpectedly high Medicare surcharges tied to RMD-driv...
SpaceX is pursuing a bold, trillion-dollar plan to become the backbone of global connectivity. As markets watch, inve...
U.S. stocks moved higher as traders shrugged off renewed fighting in Iran, with gains led by technology and consumer ...
A family of five confronts $85,000 in consumer debt and lays out a 3-to-4-year plan to regain financial footing, unde...
In a shifting rate environment, investors weigh after-tax returns. Some Schwab analysts argue that municipal bonds be...
As a new era at the Fed begins, chair kevin warsh yearns for sweeping reforms even as two price shocks complicate the...